September is Gynecological Cancer Awareness Month! The five main types are cervical, ovarian, uterine, vaginal, and vulvar cancer. Early diagnosis increases the chances of survival. #StopHPVCancer #cervicalcancer #ovariancancer #vaginalandvulvarcancer #uterinecancer #SherlockBiosciences
Sherlock Biosciences
Biotechnology Research
Boston, Massachusetts 10,596 followers
Improving health worldwide through accurate, fast and affordable diagnostic testing
About us
Sherlock Biosciences aims to disrupt molecular diagnostics with better, faster, affordable tests. With our unique Engineering Biology platforms, we are on the cusp of solving challenges ranging from faster pathogen detection and simpler testing for cancer to improved food safety. We envision a world where our products will enable users to make more effective decisions in any environment, whether in hospitals, industrial settings, the developing world, or at home. Our team and founders include Engineering Biology pioneers with world-leading expertise in CRISPR and Synthetic Biology, diagnostic industry veterans, and disease-area authorities. Together, they provide an unparalleled set of capabilities that are transforming molecular diagnostics in clinical and non-clinical settings.
- Website
-
https://sherlock.bio/
External link for Sherlock Biosciences
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Boston, Massachusetts
- Type
- Privately Held
- Founded
- 2019
- Specialties
- diagnostics, biotechnology, synthetic biology, CRISPR, and engineering biology
Locations
-
Primary
Get directions
40 Guest St
Boston, Massachusetts 02135, US
Employees at Sherlock Biosciences
-
Craig Spitzkoff
Medical Software Development
-
Julie Garlikov
Commercialization Leader | Board Member | Brand Builder, Big Idea Innovator, and Creative Risk Taker | Biotechnology | Digital Consumer Health |…
-
Amy Lyons
-
Guy Thompson II
Senior Director of Global Manufacturing at Sherlock Biosciences
Updates
-
Many people hesitate to disclose STIs due to fears of stigma and rejection. At Sherlock Biosciences, we believe that open conversations about STIs are just as important as testing and treatment. By breaking down these stigmas, we can foster broader awareness and understanding, ultimately leading to better health outcomes for everyone. Let’s work together to create a more informed and compassionate community. #HealthAwareness #STI #SherlockBiosciences Read More: https://bit.ly/3MlU1TN
-
🌍 We're witnessing a global surge in Mpox cases, underscoring the critical need for Point of Care diagnostic testing. Accurate, affordable, and accessible testing remains the first line of defense in combating outbreaks. Now more than ever, it's essential to invest in diagnostics that empower communities and protect public health. #GlobalHealth #Diagnostics #Mpox #HealthcareInnovation #PublicHealth #SherlockBiosciences Read More: https://lnkd.in/geNeKA75
New Mpox Emergency Sounds Alarm for Increased Development of Point-of-Care MDx Tests
genomeweb.com
-
A recent report highlights the trends in sexually transmitted infections (STIs) among active component service members from 2015 to 2023. The data reveals fluctuating incidence rates of various STIs, emphasizing the need for continuous monitoring and preventive measures. Regular screening and education are essential to maintaining the health and readiness of our military personnel. Stay informed and proactive about STI prevention! #STI #HealthScreening #MilitaryHealth #PromiseStudy Learn More: https://bit.ly/3yjv0FA
Sexually Transmitted Infections Among Active Component Members of the U.S. Armed Forces, 2015–2023
-
Molecular diagnostics are revolutionizing infectious disease detection. The market is expanding rapidly, fueled by technological advancements and increasing demand for personalized treatments. #SherlockBiosciences #STI #Diagnostic Learn more: https://bit.ly/4dbFKF4
Molecular Diagnostics Market Trends: Embracing Innovation, Improving Patient Outcomes, and Driving Industry Growth
Raghuraj panchabhai on LinkedIn
-
Join CEO Bryan Dechairo on the Boyd Biomedical Design Series as he discusses Sherlock Biosciences' groundbreaking work in low-income countries. With amazing support from global health giants like the Gates Foundation and #Open Philanthropy Project, we're revolutionizing tuberculosis testing, aiming for 75% coverage. #SherlockBiosciences #BoydBiomedical #Health
-
A recent study highlights the critical gap in STI testing for pregnant women, posing risks to both mothers and newborns. This is why Sherlock Biosciences is dedicated to delivering affordable, accurate and accessible diagnostics. #HealthcareInnovation #WomensHealth #MedicalDiagnostics Read more about the study. https://bit.ly/3AfdKBJ
Chlamydia and Gonorrhea Testing in Pregnancy: Time to... : Journal of Lower Genital Tract Disease
journals.lww.com
-
Screening for early detection is crucial in managing health, yet access to testing remains a significant barrier for many. At Sherlock Biosciences, we are dedicated to breaking down these barriers by developing fast, accurate, and accessible at-home diagnostic tests. Together, we can empower individuals to take charge of their health. #HealthcareInnovation #Diagnostics #PublicHealth https://bit.ly/46zfoue
Patient self-testing and disease prevention
mlo-online.com
-
Watch Julie Garlikov, our Chief Commercial Officer, as she discusses how the combination of cutting-edge technology with simple solutions can create better user experiences. #Innovation #UserExperience #SherlockBiosciences #BoydBiomedical
-
We at Sherlock Biosciences are extremely passionate about WHY we do what we do! #HealthCare4All #BreakBarriers #Innovation #SherlockBiosciences